No Clinically Significant Interaction Between Pomegranate Juice and Crestor
Pomegranate juice does not have a clinically significant interaction with Crestor (rosuvastatin) and can be consumed without dose adjustment or special precautions.
Why This Interaction is Not Concerning
Rosuvastatin has a fundamentally different metabolic profile compared to other statins that makes it resistant to most food and drug interactions:
- Rosuvastatin is NOT significantly metabolized by CYP3A4, the enzyme system responsible for most statin-food interactions 1
- Only approximately 10% of rosuvastatin undergoes metabolism, with the major metabolite formed by CYP2C9 (not CYP3A4) 1
- Greater than 90% of the active drug effect comes from the parent compound itself 1
- The drug is primarily excreted unchanged in feces (90%) 1
The Grapefruit Juice Analogy
While pomegranate juice (like grapefruit juice) can inhibit CYP3A4 and increase levels of statins metabolized through this pathway (simvastatin, lovastatin, atorvastatin), rosuvastatin clearance is explicitly "not dependent on metabolism by cytochrome P450 3A4 to a clinically significant extent" 1.
What Actually Matters for Rosuvastatin
The FDA labeling and guidelines identify specific interactions that DO require dose adjustments for rosuvastatin 1:
- Cyclosporine: Limit to 5 mg daily
- Gemfibrozil: Avoid combination; if used, max 10 mg daily
- Lopinavir/ritonavir: Limit to 10 mg daily
These interactions occur through OATP1B1 transporter inhibition or P-glycoprotein effects—mechanisms unrelated to pomegranate juice consumption.
Clinical Bottom Line
Patients taking Crestor can drink pomegranate juice without concern for drug interaction, dose modification, or increased risk of myopathy. This is a key advantage of rosuvastatin over CYP3A4-metabolized statins in patients who consume fruit juices or take multiple medications.